Global Standardized Financials

65.49 0.12(0.18%)10/04/2024
Edwards Lifesciences Corp (EW)

Income Statement
(Values in USD Thousands)
 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
Net Income366,300351,900384,900307,100
Revenue1,385,9001,598,2001,480,9001,530,200
Cost Of Revenue297,800384,200350,400343,000
gross Profit1,088,1001,214,0001,130,5001,187,200
Operating Expenses723,400776,300709,900739,000
Selling General and Administrative Expenses450,800489,700439,600468,700
Research and Development Expenses272,600285,200270,300270,300
Other Expenses2,000-1,4005,8002,200
Cost And Expenses1,021,2001,160,5001,060,3001,082,000
Operating Income364,700437,700418,400327,200
Interest Income15,5009,100
Income Tax Expense20,20058,40055,60033,000
Income Before Tax386,600409,400439,300338,500
Earning Per Share Basic0.610.580.630.51
Earning Per Share Diluted0.610.580.630.50
weighted Average Shares Outstanding602,100601,600607,000606,900
weighted Average Shares Outstanding (Diluted)604,300604,100609,500610,300
Gross Margin0.790.760.760.78
EBIT Margin0.290.330.290.37
Profit Margin0.260.220.260.20
EBITDA404,300526,400422,800569,200
Earning Before Tax Margin0.280.260.300.22